F. HOFFMANN-LA ROCHE AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 151111
 
  
 
C07D HETEROCYCLIC COMPOUNDS 8781
 
  
 
C07K PEPTIDES 5185
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 30176
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1679
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 16151
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1386
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1237
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 12113
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 891

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,393 STABLE INTRAVENOUS FORMULATIONOct 24, 17Mar 15, 18[A61K]
2017/0369,529 CELL PENETRATING PEPTIDESDec 18, 15Dec 28, 17[A61K, C07K]
2017/0241,987 METHOD OF DETERMINING RISK OF ARRHYTHMIAMay 10, 17Aug 24, 17[G01N]
2017/0202,819 PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTSJan 11, 17Jul 20, 17[A61K]
2017/0192,000 METHOD FOR MONITORING CATHEPSIN S INHIBITIONMar 10, 17Jul 06, 17[G01N, C07K]
2016/0355,575 OLIGOPEPTIDE AND METHODS FOR PRODUCING CONJUGATES THEREOFNov 13, 14Dec 08, 16[A61K, G01N, C07K]
2016/0333,066 PURIFICATION OF ERYTHROPOIETINMar 21, 16Nov 17, 16[C07K]
2016/0237,427 Tau Antisense Oligomers and Uses ThereofFeb 04, 16Aug 18, 16[C12N]
2016/0207,936 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORSDec 18, 15Jul 21, 16[C07D]
2015/0267,237 CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTIONApr 24, 13Sep 24, 15[C12P, C12N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9896433 Antiviral compoundsMar 03, 14Feb 20, 18[A61K, C07D]
9879007 Compounds for treating spinal muscular atrophyAug 26, 16Jan 30, 18[A61K, A01N, C07D]
9873709 Triazolopyridine compounds, compositions and methods of use thereofApr 27, 17Jan 23, 18[C07D]
9855270 Methods and compositions for modulating estrogen receptor mutantsMar 12, 15Jan 02, 18[A61K, C12Q]
9827244 Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral diseaseJun 01, 16Nov 28, 17[A61K, C07D]
9828340 Asymmetric synthesis of a substituted pyrrolidine-2-carboxamideFeb 18, 14Nov 28, 17[C07D]
9815904 Pertuzumab variants and evaluation thereofApr 15, 14Nov 14, 17[A61K, G01N, C07K]
9797891 Method and system for determining a biological response of a target to a soluble candidate substanceMar 04, 14Oct 24, 17[C12Q, G01N, B01L]
9778277 Process and apparatus for testing substances for potential carcinogenicityMar 19, 10Oct 03, 17[C12Q, C12M, G01N]
9754505 Method for training staff in quality controlSep 18, 14Sep 05, 17[G09B]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0210,724 ALKYNYL ALCOHOLS AND METHODS OF USEAbandonedApr 07, 17Jul 27, 17[C07D]
2017/0002,313 COMPOSITIONS AND METHODS OF OBTAINING AND USING ENDODERM AND HEPATOCYTE CELLSAbandonedMay 21, 13Jan 05, 17[A61K, C12N]
2016/0367,557 HETEROCYCLIC PYRIMIDINE CARBONIC ACID DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASEAbandonedJun 24, 16Dec 22, 16[A61K]
2016/0200,672 NEW PROCESSAbandonedMar 22, 16Jul 14, 16[C07C]
2016/0168,640 THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERSAbandonedNov 10, 15Jun 16, 16[C12Q]
2016/0158,360 METHODS AND COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS ANTAGONISTS AND HPK1 ANTAGONISTSAbandonedDec 04, 15Jun 09, 16[A61K]
2016/0136,280 STABLE INTRAVENOUS FORMULATIONAbandonedJun 20, 14May 19, 16[A61K]
2016/0074,360 COMBINED DRUG ADMINISTRATION OF DALCETRAPIB AND ORLISTATAbandonedNov 05, 15Mar 17, 16[A61K]
2016/0009,772 CELL PENETRATING PEPTIDES WHICH BIND IRF5AbandonedOct 07, 13Jan 14, 16[G01N, C07K]
2015/0306,130 CHITOSAN COVALENTLY LINKED WITH SMALL MOLECULE INTEGRIN ANTAGONIST FOR TARGETED DELIVERYAbandonedJan 24, 13Oct 29, 15[A61K, C08B]
2015/0299,143 SUBSTITUTED TRIAZOLE AND IMIDAZOLE COMPOUNDSAbandonedNov 29, 13Oct 22, 15[C07D]
2015/0290,192 INHIBITORS OF BRUTON'S TYROSINE KINASEAbandonedNov 27, 13Oct 15, 15[A61K]
2015/0274,777 KETOAMIDE IMMUNOPROTEASOME INHIBITORSAbandonedSep 30, 13Oct 01, 15[C07K]
2015/0266,920 MACROCYCLIC KETOAMIDE IMMUNOPROTEASOME INHIBITORSAbandonedOct 09, 13Sep 24, 15[C07K]
2015/0259,295 SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTSAbandonedJun 17, 13Sep 17, 15[C07D]
2015/0209,294 PHARMACEUTICAL COMPOSITION AND PROCESSAbandonedOct 31, 14Jul 30, 15[A61K]
2015/0183,827 CELL PENETRATING PEPTIDES & METHODS OF IDENTIFYING CELL PENETRATING PEPTIDESAbandonedJun 24, 13Jul 02, 15[A61K, G01N, C07K]
2015/0140,087 Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) AntagonistsAbandonedNov 11, 14May 21, 15[A61K]
2015/0133,512 N-ARYLTRIAZOLE COMPOUNDS AS LPAR ANTAGONISTSAbandonedJun 17, 13May 14, 15[C07D]
2015/0065,516 NEW BIARYL AMIDE DERIVATIVESAbandonedOct 29, 14Mar 05, 15[C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.